About this trial
In the Congenital Myopathy Research Program at Boston Children's Hospital and Harvard Medical School, the researchers are studying the congenital myopathies (neuromuscular diseases present from birth), including central core disease, centronuclear/myotubular myopathy, congenital fiber type disproportion, multiminicore disease, nemaline myopathy, rigid spine muscular dystrophy, SELENON (SEPN1), RYR1 myopathy, ADSS1 (ADSSL) Myopathy and undefined congenital myopathies. The primary goal of the research is to better understand the genes and proteins (gene products) involved in muscle functioning and disease. The researchers hope that our studies will allow for improved diagnosis and treatment of individuals with congenital myopathies in the future. For more information, visit the Laboratory Website at www.childrenshospital.org/research/beggs
Eligibility criteria
Qualifiers
Individuals with a clinical or suspected diagnosis of a congenital myopathy and their family members
Disqualifiers
No specific exclusion criteria. Our studies do not include myotonia congenita or related conditions.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Boston Children's Hospital
Lead sponsor
Muscular Dystrophy Association
Collaborator